Marc A Probst1, Malkeet Gupta2, Gregory W Hendey3, Robert M Rodriguez4, Gary Winkel5, George T Loo6, William R Mower7. 1. Department of Emergency Medicine, Icahn School of Medicine at Mount Sinai, New York, NY. Electronic address: mprobst@gmail.com. 2. UCLA Department of Emergency Medicine, Ronald Reagan UCLA Medical Center, Los Angeles, CA; Antelope Valley Hospital Emergency Department, Lancaster, CA. 3. UCLA Department of Emergency Medicine, Ronald Reagan UCLA Medical Center, Los Angeles, CA; UCSF Fresno, Community Regional Medical Center, Fresno, CA. 4. Zuckerberg San Francisco General Hospital, Department of Emergency Medicine, UCSF School of Medicine, San Francisco, CA. 5. Department of Oncological Sciences, Mount Sinai School of Medicine, New York, NY. 6. Department of Emergency Medicine, Icahn School of Medicine at Mount Sinai, New York, NY. 7. UCLA Department of Emergency Medicine, Ronald Reagan UCLA Medical Center, Los Angeles, CA.
Abstract
STUDY OBJECTIVE: We determine the prevalence of significant intracranial injury among adults with blunt head trauma who are receiving preinjury anticoagulant or antiplatelet medications. METHODS: This was a multicenter, prospective, observational study conducted from December 2007 to December 2015. Patients were enrolled in 3 emergency departments (EDs) in the United States. Adults with blunt head trauma who underwent neuroimaging in the ED were included. Use of preinjury aspirin, clopidogrel, and warfarin was recorded. Data on direct oral anticoagulants were not specifically recorded. The primary outcome was prevalence of significant intracranial injury on neuroimaging. The secondary outcome was receipt of neurosurgical intervention. RESULTS: Among 9,070 patients enrolled in this study, the median age was 53.8 years (interquartile range 34.7 to 74.3 years) and 60.7% were men. A total of 1,323 patients (14.6%) were receiving antiplatelet medications or warfarin, including 635 receiving aspirin alone, 109 clopidogrel alone, and 406 warfarin alone. Compared with that of patients without any coagulopathy, the relative risk of significant intracranial injury was 1.29 (95% confidence interval [CI] 0.88 to 1.87) for patients receiving aspirin alone, 0.75 (95% CI 0.24 to 2.30) for those receiving clopidogrel alone, and 1.88 (95% CI 1.28 to 2.75) for those receiving warfarin alone. The relative risk of significant intracranial injury was 2.88 (95% CI 1.53 to 5.42) for patients receiving aspirin and clopidogrel in combination. CONCLUSION: Patients receiving preinjury warfarin or a combination of aspirin and clopidogrel were at increased risk for significant intracranial injury, but not those receiving aspirin alone. Clinicians should have a low threshold for neuroimaging when evaluating patients receiving warfarin or a combination of aspirin and clopidogrel.
STUDY OBJECTIVE: We determine the prevalence of significant intracranial injury among adults with blunt head trauma who are receiving preinjury anticoagulant or antiplatelet medications. METHODS: This was a multicenter, prospective, observational study conducted from December 2007 to December 2015. Patients were enrolled in 3 emergency departments (EDs) in the United States. Adults with blunt head trauma who underwent neuroimaging in the ED were included. Use of preinjury aspirin, clopidogrel, and warfarin was recorded. Data on direct oral anticoagulants were not specifically recorded. The primary outcome was prevalence of significant intracranial injury on neuroimaging. The secondary outcome was receipt of neurosurgical intervention. RESULTS: Among 9,070 patients enrolled in this study, the median age was 53.8 years (interquartile range 34.7 to 74.3 years) and 60.7% were men. A total of 1,323 patients (14.6%) were receiving antiplatelet medications or warfarin, including 635 receiving aspirin alone, 109 clopidogrel alone, and 406 warfarin alone. Compared with that of patients without any coagulopathy, the relative risk of significant intracranial injury was 1.29 (95% confidence interval [CI] 0.88 to 1.87) for patients receiving aspirin alone, 0.75 (95% CI 0.24 to 2.30) for those receiving clopidogrel alone, and 1.88 (95% CI 1.28 to 2.75) for those receiving warfarin alone. The relative risk of significant intracranial injury was 2.88 (95% CI 1.53 to 5.42) for patients receiving aspirin and clopidogrel in combination. CONCLUSION:Patients receiving preinjury warfarin or a combination of aspirin and clopidogrel were at increased risk for significant intracranial injury, but not those receiving aspirin alone. Clinicians should have a low threshold for neuroimaging when evaluating patients receiving warfarin or a combination of aspirin and clopidogrel.
Authors: Michael Ganetsky; Gregory Lopez; Tara Coreanu; Victor Novack; Steven Horng; Nathan I Shapiro; Kenneth A Bauer Journal: Acad Emerg Med Date: 2017-06-05 Impact factor: 3.451
Authors: Crispijn L van den Brand; Tanya Tolido; Anna H Rambach; Myriam G M Hunink; Peter Patka; Korné Jellema Journal: J Neurotrauma Date: 2016-05-09 Impact factor: 5.269
Authors: Jerry Lee Howard; Mark D Cipolle; Sarah A Horvat; Victoria M Sabella; James F Reed; Gerard Fulda; Glen Tinkoff; Michael D Pasquale Journal: J Trauma Date: 2009-06
Authors: Andy S Jagoda; Jeffrey J Bazarian; John J Bruns; Stephen V Cantrill; Alisa D Gean; Patricia Kunz Howard; Jamshid Ghajar; Silvana Riggio; David W Wright; Robert L Wears; Aric Bakshy; Paula Burgess; Marlena M Wald; Rhonda R Whitson Journal: Ann Emerg Med Date: 2008-12 Impact factor: 5.721
Authors: François Mathieu; Armaan K Malhotra; Jerry C Ku; Frederick A Zeiler; Jefferson R Wilson; Farhad Pirouzmand; Damon C Scales Journal: Neurotrauma Rep Date: 2022-08-10